English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Nanjing University of Chinese Medicine, Nanjing, China; Shenogene Pharma Group, Beijing, China; Department of Oncology, Nanjing Jinling Hospital, Nanjing, China Contributions: (I) Conception and design: S Qin; (II) Administrative support: X Liu, F Liao; (III) Provision of study materials or patients: X Zheng, Y Gou; (IV) Collection and assembly of data: Z Li, C Chen; (V) Data analysis and interpretation: B Ye; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Shukui Qin. Yanggongjing NO. 34-34, Taiping South Road, Nanjing, China. Email: qinsk@csco.org.cn.

translational cancer research

Neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers to predict relapse and survival in posthepatectomy HBV-related hepatocellular carcinoma: a meta-analysis and preliminary immune perspective